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1 |  INTRODUCTION
The progressive rise in diabetes mellitus worldwide is paral-
leled by severe complications including retinopathy, neurop-
athy, and nephropathy (Valencia & Florez, 2017; Zhou et al., 
2016). Approximately 40% of diabetic patients develop dia-
betic nephropathy (DN) (Reutens, 2013; Saran et al., 2018), 
which is characterized by albuminuria and loss of kidney 
function (Alicic, Rooney, & Tuttle, 2017; Reutens, 2013). 
DN is the leading cause of chronic kidney disease (CKD) and 
end-stage renal disease (ESRD) accounting for around half 
of all patients entering dialysis, and is associated with lower 
quality of life, increased cardiovascular risk, and reduced sur-
vival (Saran et al., 2018).
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Abstract
Diabetic nephropathy (DN) is associated with albuminuria and loss of kidney func-
tion and is the leading cause of end-stage renal disease. Despite evidence of sex-
associated differences in the progression of DN in human patients, male mice are 
predominantly being used in preclinical DN research and drug development. Here, 
we compared renal changes in male and female uninephrectomized (UNx) db/db 
C57BLKS mice using immunohistochemistry and RNA sequencing. Male and fe-
male UNx db/db mice showed similar progression of type 2 diabetes, as assessed by 
obesity, hyperglycemia, and HbA1c. Progression of DN was also similar between 
sexes as assessed by kidney and glomerular hypertrophy as well as urine albumin-
to-creatinine ratio being increased in UNx db/db compared with control mice. In 
contrast, kidney collagen III and glomerular collagen IV were increased only in fe-
male UNx db/db as compared with respective control mice but showed a similar 
tendency in male UNx db/db mice. Comparison of renal cortex transcriptomes by 
RNA sequencing revealed 66 genes differentially expressed (p < .01) in male versus 
female UNx db/db mice, of which 9 genes were located on the sex chromosomes. In 
conclusion, male and female UNx db/db mice developed similar hallmarks of DN 
pathology, suggesting no or weak sex differences in the functional and structural 
changes during DN progression.
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Except for the recent emergence of SGLT2 inhibitors 
and GLP-1 receptor agonists (Hocher & Tsuprykov, 2017) 
for nephroprotection in patients with diabetes, the DN thera-
peutic landscape has remained largely unchanged in the past 
25  years (Johnson & Spurney, 2015; Wanner et al., 2016). 
This gap is largely due to the absence of reliable markers of 
disease risk and progression, as well as an incomplete under-
standing of the underlying mechanisms of DN in preclinical 
models and man. Thus, the development of animal models 
that more closely resemble the pathophysiology of human 
DN is urgently needed to support the advancement of novel 
and efficient therapies.
Several potential animal models of DN have been explored 
(Kitada, Ogura, & Koya, 2016). Notably, the db/db mouse 
which carries a homozygous inactivating leptin receptor 
mutation resulting in defective leptin signalling (Chen et al., 
1996; Lee et al., 1996) and consequently hyperphagia, obe-
sity, insulin resistance, and hyperglycaemia (Lee & Bressler, 
1981) have been extensively utilized (Tesch & Lim, 2010). 
These mice develop many of the pathological features of 
early human DN, including albuminuria and mesangial ma-
trix expansion (Cohen, Lautenslager, & Shearman, 2001), but 
only mild glomerulosclerosis. Accordingly, to accelerate the 
progression of DN, and hence to more closely mimic human 
pathophysiology, unilateral nephrectomy can be applied lead-
ing to additional hemodynamic stress on the remaining kid-
ney (Bower, Brown, Steffes, Vernier, & Mauer, 1980).
Despite evidence of sex-associated differences in the 
progression of DN in human patients (Carrero, Hecking, 
Chesnaye, & Jager, 2018; Chang et al., 2016; Piccoli, 
Alrukhaimi, Liu, Zakharova, & Levin, 2018), male mice are 
predominantly being used in preclinical DN research and 
drug development including the majority of previous studies 
in the UNx db/db mouse model of DN (Ninichuk, Khandoga, 
et al., 2007; Ninichuk, Kulkarni, Clauss, & Anders, 2007; 
Senador, Kanakamedala, Irigoyen, Morris, & Elased, 2009; 
Yiu et al., 2016). In this study, we therefore compared the 
progression of DN in male and female UNx db/db C57BLKS 
mice using standard biochemical and histological endpoints, 
as well as renal cortex transcriptomic changes.
2 |  MATERIALS AND METHODS
2.1 | Animals
All animal experiments were conducted in accordance with 
internationally accepted principles for the care and use of 
laboratory animals. The study was approved by the Danish 
Committee for Animal Research and covered by an institu-
tional license issued to Tanja Xenia Pedersen (permit num-
ber: 2013-15-2934-00843). Animals used in the studies were 
allowed to acclimatize for at least one week and kept in a 
light-, temperature-, and humidity-controlled room (12-hr 
light:12-hr dark cycle; 22°C–24°C and 50% relative humid-
ity). The animals had free access to standard chow diet and 
tap water.
Male and female C57BLKS/J db/db mice and male db/+ 
mice (JanVier) or BKS female db/+ mice (Charles River) ar-
rived one week prior to surgery. At 7–8 weeks of age, db/db 
male and female mice were uninephrectomized (UNx), and 
sham-operated db/+ male and female mice served as controls. 
UNx surgery. Mice were anesthetized by isoflurane inhala-
tion, and a small incision was made to the left of the spine to 
expose the kidney. The left urethra, kidney artery, and kidney 
vein were identified and ligated with suture. Hereafter, the 
left kidney was removed. Sham surgery. For sham surgery, 
the kidney was exposed and gently manipulated, but not re-
moved. For postoperative recovery, mice received 5 mg/kg 
enrofloxacin and 5 mg/kg carprofen administered subcutane-
ously for up to 2 days postsurgery. The mice were terminated 
16 weeks after surgery, and the right kidneys were sampled 
for RNA sequencing, histology, and stereology.
2.2 | Blood and urine analyses
Blood glucose was measured weekly for the first 4  weeks 
postsurgery and from there on every third week by collect-
ing blood into heparinized glass capillary tubes and imme-
diate suspension in glucose/lactate system solution buffer 
(EKF-diagnostics). Blood glucose was measured using a 
BIOSEN c-Line glucose meter (EKF-diagnostics) accord-
ing to the manufacturer's instructions. Glycated haemoglobin 
A1c (HbA1c) levels were measured at termination (16 weeks 
after surgery) using commercial kits (Roche Diagnostics) 
on a CobasTM C-501 autoanalyzer (Roche Diagnostics). At 
study week 15, spot urine samples were collected directly 
from the penis/vulva to determine the urinary albumin-to-
creatinine ratio (ACR). Urine creatinine was measured using 
the CREP2 kit (Roche Diagnostics) on a CobasTM C-501 
autoanalyzer. Urinary albumin was measured using a mouse 
albumin ELISA kit (Bethyl Laboratories, Inc.). Plasma 
blood urea nitrogen (BUN) levels were measured at termina-
tion (16 weeks after surgery) using commercial kits (Roche 
Diagnostics) on the Cobas™ C-501 autoanalyzer.
2.3 | Histology
At termination, the right kidney was dissected, weighed, di-
vided sagitally, and one half was fixed in 10% neutral buff-
ered formalin (4% formaldehyde, Hounisen) for 24 hr at room 
temperature. The fixed kidney tissue was cut transversely 
into 2 mm slabs using a systematic razor blade fractionator 
and a random starting position. The resulting 4–5 slabs were 
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dehydrated and infiltrated with paraffin in a tissue proces-
sor (VIP5, Sakura) and then embedded with the cut surface 
down. A single 3  µm top section was cut on a microtome 
(Thermo Scientific) from each block representing a system-
atic uniform random sample of the half kidney.
2.3.1 | Immunochemical stain and 
stereological analyses
Periodic acid–Schiff (PAS) staining was performed using 
standard procedures. Briefly, kidney sections were deparaffi-
nized and oxidized in 0.5% periodic acid (Sigma-Aldrich). 
Next, sections were incubated with Schiff's reagent (Sigma-
Aldrich) and counterstained with Mayer's hematoxylin 
(Dako). Sections were dehydrated and mounted with Pertex 
(Histolab).
Stereological estimation of glomerular volume was de-
termined using the Cavalieri principle of uniform random 
systematic sampling in combination with point counting 
(Gundersen, Jensen, Kiêu, & Nielsen, 1999). PAS-stained 
slides were scanned under a 20× objective in an Aperio 
Scanscope AT slide scanner and imported into the stereol-
ogy module of the Visiopharm Integrator Software (VIS, 
Visiopharm). An overlay grid system with an appropriate 
density was used to count all points hitting glomeruli.
2.3.2 | Immunohistochemical 
stains and quantification of fibrosis and 
glomerulosclerosis
Immunohistochemical (IHC) stains were performed using 
standard procedures. Collagen III IHC stain was used to 
quantify renal fibrosis. Kidney sections were deparaffinized. 
Antigen retrieval was performed by proteolytic digestion in 
0.4% pepsin (Sigma-Aldrich). Endogenous peroxidase ac-
tivity was blocked in 1% H2O2 in TBS followed by protein 
blocking in blocking buffer (5% swine serum, 1% BSA, 0.05% 
Tween 20 in TBS). Subsequently, sections were incubated 
for one hour with goat anticollagen III antibody (Southern 
Biotech, cat. no. 1330-01) diluted 1:100 in blocking buffer. 
The primary antibody was detected using Brightvision anti-
goat poly-HRP system (Immunologic) and visualized with 
Liquid DAB + substrate chromogen system (Dako). Sections 
were counterstained in Gill's hematoxylin (Sigma-Aldrich) 
prior to dehydration and mounting with Pertex.
Fluorescent IHC for double staining of podocin and col-
lagen IV was performed to quantify the content of collagen 
IV inside glomeruli as a measure of glomerulosclerosis as 
follows: After deparaffinization, antigen retrieval was per-
formed by boiling sections in TEG buffer (Tris-EGTA pH 9, 
Sigma-Aldrich) in a microwave oven for 30 min. Endogenous 
peroxidase activity was blocked in 1% H2O2 in TBS followed 
by protein blocking in blocking buffer. Subsequently, sec-
tions were incubated for 1 hour with primary antibody no. 1, 
rabbit anti-podocin (cat. No. P0372, Sigma-Aldrich) diluted 
1:12,000 in blocking buffer for one hour. Sections were incu-
bated with secondary antibody no. 1, HRP-conjugated donkey 
anti-rabbit (Jackson ImmunoResearch cat# 711-036-152) for 
30 min followed by signal amplification using TSA plus FITC 
system (Perkin Elmer, NEL741B001KT). Subsequently, pri-
mary antibody no. 2, rabbit anticollagen IV (Novusbio cat# 
NB110-59981) diluted 1:50 in blocking buffer, was added 
and sections incubated for one hour. Next, sections were in-
cubated in secondary antibody no. 2, AlexaFluor 790-con-
jugated donkey anti-rabbit (Jackson ImmunoResearch cat# 
711-655-152), for 30  min, counterstained with DAPI (Life 
technologies), and mounted with Prolong Diamond mounting 
medium (Life technologies).
Total kidney collagen III mass was determined using 
image analysis. Stained slides were scanned under a 20x 
objective in an Aperio Scanscope AT slide scanner and im-
ported into an image analysis module in VIS. A Bayesian 
classifier was trained to detect DAB labeled collagen III and 
other tissue components. The total collagen III mass was cal-
culated as the collagen III area fraction (area collagen III/
total tissue area in sections) multiplied by the kidney weight.
Total glomerular collagen IV volume was determined 
similarly to collagen III mass. Slides were scanned under a 
20× objective in an Olympus VS120 slide scanner with the 
appropriate fluorescent filters. The podocin-positive FITC-
labeled area was used to identify all glomeruli. A simple 
threshold was used to detect AlexaFluor 790 labeled collagen 
IV inside glomeruli. Total collagen IV volume was calcu-
lated as the collagen IV area fraction (area collagen IV inside 
glomeruli/total glomerular area in sections) multiplied by the 
total glomerular volume as assessed by stereology.
2.4 | RNA sequencing
RNA from snap-frozen kidney samples (~15 mg per ani-
mal) stored at −80°C was extracted using the NucleoSpin® 
8 RNA kit (Macherey-Nagel) and a vacuum manifold. 
The RNA quantity was measured using Qubit® (Thermo 
Scientific), and RNA quality determined using a bioana-
lyzer with RNA 6,000 Nano kit (Agilent). About 500  ng 
purified RNA from each sample was used to generate a 
cDNA library using the NEBNext® Ultra™ II Directional 
RNA Library Prep Kit for Illumina (New England 
Biolabs). cDNA libraries were sequenced (75 base-pair, 
single end reads) on a NextSeq 500 using NextSeq 500/550 
High Output Kit V2 (Illumina). Reads were aligned to 
the GRCm38 v89 Ensembl Mus musculus genome using 
STAR software (v.2.5.2a) (Dobin et al., 2013) with default 
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parameters. A differential gene expression analysis was 
performed using the R package DEseq2 (Love, Huber, & 
Anders, 2014), and genes were considered significant at a 
false discovery rate (FDR) cut-off of 0.01. A gene set anal-
ysis was conducted with the R package Piano (Väremo, 
Nielsen, & Nookaew, 2013) combined with gene annota-
tion from the Reactome database (Haw & Stein, 2012).
2.5 | Statistical analyses
Results are presented as mean ± standard error of mean (SEM). 
Two-way analysis with Tukey's multiple comparisons test was 
used to test differences between groups. Urinary ACR values 
were log10-transformed before group comparisons. Differences 
were considered statistically significant when p < .05.
3 |  RESULTS
3.1 | Male and female UNx db/db mice 
display increased body weight, blood glucose, 
and HbA1c
Compared with sham-operated db/+ controls, male and fe-
male UNx db/db mice displayed a substantial increase in body 
weight throughout the 16-week study period, resulting in a sig-
nificant body weight difference at termination (30.2 ± 0.9 Sham 
db/+ vs. 43.2 ± 1.7 g UNx db/db males, p < .001; 24.0 ± 0.4 
Sham db/+ vs. 39.3  ±  2.3  g UNx db/db females, p  <  .001, 
Figure 1a). There was no statistically significant difference 
in body weight between UNx db/db males versus UNx db/db 
females (p =  .36). Blood glucose was increased in male and 
female UNx db/db mice from the beginning of the study and 
remained significantly elevated until termination (Figure 1b). 
Correspondingly, HbA1c levels were significantly elevated in 
UNx db/db mice compared with sham db/+ controls 16 weeks 
postsurgery (4.0 ± 0.1 Sham db/+ vs. 8.2 ± 1.8% UNx db/db 
males, p <  .001; 3.8 ± 0.1 Sham db/+ vs. 8.8 ± 0.6% UNx 
db/db females, p <  .001, Figure 1c). For both blood glucose 
(p = .91) and HbA1c levels (p = .77), no significant change was 
found between UNx db/db males versus UNx db/db females.
3.2 | Male and female UNx db/db 
mice display increased urine ACR, renal 
hypertrophy, and glomerulosclerosis
At study week 15, male and female UNx db/db mice displayed 
a significant increase in the urine ACR compared with controls 
(154 ± 92.8 Sham db/+ vs. 1,251 ± 306 µg/mg UNx db/db males 
week 15, p < .001; 44 ± 6.9 Sham db/+ vs. 2,263.8 ± 505 µg/
mg UNx db/db females week 15, p < .001, Figure 2a), while 
no change was found between UNx db/db males versus UNx 
db/db females (p = .73). There was no significant increase in 
plasma BUN between UNx db/db mice and db/+ controls of the 
same sex (7.7 ± 0.9 Sham db/+ vs. 12.9 ± 0.6 mmol/L UNx db/
db males, p = .11; 9.4 ± 0.7 Sham db/+ vs. 13.0 ± 2.0 mmol/L 
UNx db/db females, p = .29, Figure 2b), neither between males 
and females UNx db/db mice 16 weeks postsurgery. At termi-
nation, male and female UNx db/db mice displayed renal hy-
pertrophy as indicated by significantly increased kidney weight 
compared with sham db/+ controls (176 ± 6.7 Sham db/+ vs. 
258 ± 9.5 mg UNx db/db males, p <  .001; 140 ± 5.5 Sham 
db/+ vs. 266 ± 10.5 mg UNx db/db females, p < .001, Figure 
2c). Four sham-operated male db/+ were excluded at the time 
F I G U R E  1  Male and female UNx db/db mice display increased body weight, blood glucose, and HbA1c indicating development of type 2 
diabetes. (a) Body weight measured weekly in male and female sham db/+ and UNx db/db mice. Statistical analysis was performed on body weight 
measurements at week 16. (b) Blood glucose was assessed weekly from study start until week 4 and from there on every third week. Statistical 
analysis was performed on blood glucose measurements at week 15. ***p < .001 UNx db/db female versus Sham db/+ female; ###p < .001 UNx 
db/db male versus Sham db/+ male. (c) Percentage of glycated hemoglobin A1c (HbA1c) was measured at termination 16 weeks after surgery. 
Values represent mean + SEM in Sham db/+, male (n = 9), UNx db/db, male (n = 12–16), Sham db/+, female (n = 8) and UNx db/db female 
(n = 10–14); ***p < .001 UNx db/db versus Sham db/+
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of termination due to hydronephrosis, whereas none of the 
female db/+ or UNx db/db mice developed hydronephrosis. 
Renal collagen III levels were significantly increased in female 
UNx db/db mice compared with female sham db/+ controls 
(21.7 ± 1.1 Sham db/+ vs. 27.1 ± 0.9 mg UNx db/db females, 
p < .01, Figure 2d), whereas no statistically significant change 
was found in male UNx db/db mice versus male sham db/+ 
controls (p =  .35). For UNx db/db males versus UNx db/db 
females, no difference was found in kidney weight (p = .91) 
and renal collagen III levels (p = .29).
Representative images of PAS-stained renal cortex from 
female sham db/+ and UNx db/db mice 16 weeks after sur-
gery demonstrated increased incidence of tubular dilation and 
glomerular hypertrophy in UNx db/db kidneys (Figure 3a). 
Stereological quantitation revealed increased total glomer-
ular volume in both male and female UNx db/db mice com-
pared with their respective controls (2.7 ± 0.1 Sham db/+ vs. 
4.4 ± 0.2 mm3 UNx db/db males, p < .01; 2.7 ± 0.2 db/+ Sham 
vs. 5.0 ± 0.4 mm3 UNx db/db females, p < .001, Figure 3b). 
In addition, no difference was found in total glomerular vol-
ume in UNx db/db males versus UNx db/db females (p = .27). 
Assessment of glomerulosclerosis (Figure 3c) was performed 
by double immunohistochemistry for podocin (podocytes) and 
collagen IV (fibrosis). The podocin stain was used to identify 
glomeruli with intraglomerular collagen IV as a proxy for glo-
merulosclerosis. Quantitative image analysis indicated a signif-
icant increase in glomerular IV collagen in UNx db/db females 
compared with sham db/+ females (1.1 ± 0.2 Sham db/+ vs. 
1.8 ± 0.2 mm3 UNx db/db females, p <  .05). In male mice, 
glomerular collagen IV was, however, not increased in UNx db/
db compared with sham db/+ controls (0.8 ± 0.1 Sham db/+ vs. 
1.3 ± 0.1 mm3 UNx db/db males, p = .088, Figure 3d). There 
was no significant change in glomerular collagen IV in UNx db/
db males versus UNx db/db females (p = .07).
3.3 | The kidney transcriptome of male UNx 
db/db mice versus Sham db/+
To further explore sex-associated differences in the kid-
ney, we compared gene expression patterns in renal cortex 
between male and female UNx db/db mice using RNA se-
quencing. Surprisingly, we uncovered only 66 genes that 
were differentially expressed between male and female 
UNx db/db mice out of the whole transcriptome (~22.000 
genes) (Figure 4). Of these genes, 30 genes were upregu-
lated in female UNx db/db mice and 36 genes were upregu-
lated in male UNx db/db mice. None of the 66 identified 
genes have known associations with DN susceptibility or 
progression. Interestingly, 9 of the genes regulated (~14% 
of the total differentially expressed genes) are located on the 
sex chromosomes. On the X chromosome, Pbdc2, Ddx3x, 
Kdm6a, and Eif2s3x were upregulated in female UNx mice, 
whereas Chst7 was upregulated in male UNx db/db mice 
(Figure 4). The regulated Kdm5d, Ddx3y, Uty, and Eif2s3y 
were all restricted to the Y chromosome (Figure 4). A gene 
set enrichment analysis was used to identify overrepre-
sented gene sets in either male or female UNx db/db mice. 
No significantly enriched pathways were identified, sug-
gesting that the progression of DN in males and females is 
also highly similar on the mRNA level.
4 |  DISCUSSION
The db/db mouse is one of the most widely used animal 
models of diabetes and presents with renal complications 
(Tesch & Lim, 2010). Here, we provide a direct comparison 
of the DN severity/phenotype in male and female UNx db/db 
mice 16 weeks after surgery, to assess potential sex specific 
F I G U R E  2  Male and female UNx 
db/db mice display renal hypertrophy and 
increased urine ACR. (a) Urine albumin-to-
creatinine ratio (ACR) in spot urine samples 
collected 15 weeks after surgery. (b) Plasma 
BUN collected at termination (16 weeks 
after surgery). (c) Kidney weight (mg). 
(d) Total collagen III (mg) in the kidney 
was quantified using Visiopharm. Values 
represent mean + SEM in Sham db/+, male 
(n = 5–9), UNx db/db, male (n = 5–12), 
Sham db/+, female (n = 8) and UNx db/db 
female (n = 7–10); ***p < 00.1, **p < .01 
UNx db/db versus Sham db/+
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differences of high value for preclinical and clinical studies. 
Based on a series of state of the art biochemical, histologi-
cal, and transcriptional analyses, we demonstrate that the DN 
phenotype is highly conserved across sex.
Recently, the National Institutes of Health has required 
that grant applications account for sex as a biological variable 
in preclinical research (Clayton & Collins, 2014) emphasiz-
ing the importance and urgency of addressing sex differences 
in research. For years, a serious male bias may have obscured 
potential key sex differences in clinical trials (Beery, 2018), 
as illustrated by the poorer treatment outcomes for women 
with female patients experiencing higher rates of adverse 
drug events than men (Franconi, Brunelleschi, Steardo, & 
Cuomo, 2007). Traditionally, the bias toward male subjects 
have centered around a concern for confounding contribution 
from the estrous cycle. However, empirical studies and anal-
yses addressing these concerns in several rodent species have 
now demonstrated that females may not be more variable than 
males (Beery, 2018; Prendergast, Onishi, & Zucker, 2014).
The C57BLKS db/db mouse is one of the most widely 
used animal models of diabetes with renal complications 
(Tesch & Lim, 2010), as substantiated by albuminuria and 
mesangial matrix expansion (Harlan et al., 2018; Heuer et 
al., 2017; Tang et al., 2017). In agreement with the literature, 
the present study demonstrated albuminuria and glomerular 
hypertrophy in the UNx db/db model. Both male and female 
UNx db/db mice showed similar progressive changes in body 
weight, hyperglycemia, and HbA1c, indicating a comparable 
diabetic phenotype between sexes. UNx did not influence the 
severity and progression of the diabetic phenotype in UNx 
db/db mice when compared with nonoperated db/db mice 
(Cohen et al., 2001; Lee & Bressler, 1981; Terami et al., 
2014). Furthermore, similar levels of renal and glomerular 
hypertrophy were observed in male and female UNx db/db 
mice, along with increased urine ACR. Male and female UNx 
db/db mice presented with similar plasma BUN levels, and 
no significant differences were found between UNx db/db 
mice and controls within the same sex either indicating only 
mild kidney disease in the UNx db/db mouse. Although renal 
collagen III was only significantly increased in female UNx 
db/db mice only, male UNx db/db mice also showed elevated 
levels of renal collagen III. In comparison, costaining with 
podocin and collagen IV was used to assess glomeruloscle-
rosis, as glomerular collagen IV has been associated with the 
development of glomerulosclerosis in preclinical and clinical 
studies (Ikeda et al., 1991; Lee et al., 1998; Tamsma et al., 
F I G U R E  3  Increased glomerular volume and glomerulosclerosis in UNx db/db mice. (a) Representative images of PAS-stained kidney 
sections from female Sham db/+ and UNx db/db mice. The arrows represent dilated tubules. Scale bar 100 µm. (b) Total glomerular volume 
quantified by stereology on PAS-stained kidney sections at week 16. (c) A double immunohistochemical stain for podocin (green) and collagen 
IV (yellow) was performed to quantify glomerulosclerosis (white overlay). (d) Total glomerular collagen IV was quantified using stereology on 
podocin/collagen IV double stained kidney sections at week 16. Values represent mean + SEM in Sham db/+, male (n = 5), UNx db/db, male 
(n = 12), Sham db/+, female (n = 5–8) and UNx db/db female (n = 10); *p < .05, **p < .01, ***p < .001 UNx db/db versus Sham db/+
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1994). Glomerular collagen IV differed modestly between 
male and female UNx db/db mice, with female mice exhib-
iting significantly increased intraglomerular collagen IV. 
However, male mice also exhibited a strong tendency toward 
glomerulosclerosis. Therefore, while subtle sex differences 
exist in the UNx db/db model, no physiologic meaningful dif-
ferences were observed in the DN phenotype of male versus 
female mice in this present study.
To explore the influence of sex on the renal transcriptome, 
we performed kidney cortex RNA sequencing and revealed 
that only 66 genes were significantly regulated between male 
and female UNx db/db mice. None of the 66 identified genes 
have known associations with DN susceptibility or progres-
sion. The X chromosome located gene, Chst7, found to be 
upregulated in male UNx db/db mice, encodes the enzyme 
carbohydrate sulfotransferase 7. The enzyme catalyzes the 
transfer of sulfate groups to N-acetylgalactosamine, and sul-
phated N-acetylgalactosamine have been implicated in many 
biological processes including extracellular matrix deposition 
(Kitagawa, Fujita, Ito, & Sugahara, 2000), suggesting that this 
gene might be implicated in DN progression. The genes Eif2s3x 
and Ddx3x, located on the X chromosome and upregulated in 
female UNx db/db mice, are homologues to the Y-linked genes 
Eif2s3y and Ddx3y upregulated in male UNx db/db mice, un-
derlining the similar DN phenotype of the two sexes.
Overall, our observations are in agreement with a similar 
study Ma et al. (2019) comparing male and female eNOS−/− 
db/db mice and concluding that no sex difference exists in 
renal structural and functional injury. In a different study 
Østergaard et al. (2016), investigating the influence of mouse 
strain on the susceptibility to kidney injury, differences in body 
weight, blood glucose, and plasma insulin levels were shown 
between male and female DBA/2J db/db mice. However, 
these differences in the diabetic phenotype did not translate 
into differences on the development of urinary ACR levels. 
Overall, studies indicate that sex does not exert a major im-
pact on the susceptibility to or progression of DN in the db/db 
mouse model. In accordance to previous reports (Ninomiya, 
Inomata, & Ogihara, 1999; Springer et al., 2014), we observed 
several cases of hydronephrosis in male mice exclusively. The 
susceptibility to hydronephrosis and pyelonephritis (Harlan et 
al., 2018; Springer et al., 2014) in male db/db mice may pose 
an argument for selecting female over male mice to further re-
fine the db/db model of DN. However, all together, data do not 
support a biological rationale for using male or female mice 
F I G U R E  4  Transcriptional changes in the cortical kidney 
between male and female UNx db/db mice. The heat map shows the 
log2 fold change of significantly regulated genes (p < .01) between 
male and female UNx db/db mice. Gene names highlighted in red color 
are located on the X chromosome, while gene names highlighted in 
blue color are located on the Y chromosome. UNx db/db, male (n = 8) 
and UNx db/db female (n = 8)
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only in preclinical research and drug development in DN. Like 
most animal models of DN, the UNx db/db mouse does not 
capture the functional glomerular decline associated with se-
vere progression of DN (Heuer et al., 2017; Zhou, Cheung, 
Liu, & Huang, 2014). The lack of mouse models that exhibit 
the spectrum of pathological renal changes during DN pro-
gression has been a significant impediment for the develop-
ment of new treatments. This may mainly be driven by the 
absence of hypertension during late stage DN, which is the 
main risk factor associated with progression of DN to ESRD 
(Betz & Conway, 2014; Conway et al., 2011; Heerspink & 
Zeeuw, 2011). The use of an adeno associated virus vector 
to overexpress the renin gene in the db/db UNx mouse model 
offers an intriguing means of adding this hypertensive compo-
nent to both accelerate and progress the disease phenotype to 
an advanced stage of DN (Harlan et al., 2018).
In conclusion, the UNx db/db model recapitulates hall-
marks of early-stage DN and can be used to study aspects 
of initial disease progression. In addition, our results suggest 
that both male and female UNx db/db mice can be used in 
future DN studies, as only subtle sex differences were found.
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